Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets

The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly active MS (HAMS), poses a number of difficult problems for specialists, including not only the choice of a highly effective disease-modifying drug for MS (DMDMS), but also conditions for the timely and s...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika
Médium: Artigo
Jazyk:Russo
Vydáno: IMA-PRESS LLC 2020-10-01
Edice:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Témata:
highly active multiple sclerosis
disease-modifying drugs for multiple sclerosis
cladribine tablets
On-line přístup:https://nnp.ima-press.net/nnp/article/view/1459
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky